Cefepime Seizure Risk On 6/26/2012, the FDA annouced an a risk for seizure when cefepime is not dose-adjusted for renal dysfunction. The Drug Safety Communication announced the increased seizure risk based on on 59 cases of non-convulsive status epilepticus Continue reading Seizure Risk for Cefepime if not Dose Adjusted→